tradingkey.logo
搜索

Denali Therapeutics Inc

DNLI
添加自选
24.040USD
+0.470+1.99%
收盘 07-28 16:00美东报价延迟15分钟
3.81B总市值
亏损市盈率 TTM

DNLI 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Denali Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Denali Therapeutics Inc财报日历

最新发布
8月 6, 2026
每股收益 / 预测值
--/-0.67
营业收入 / 预测值
--/14.61M
报告期
FY2025 财报
营业收入(YoY)
--
--
每股收益(YoY)
-2.97
-15.49%
分析师评级
BUY
2026/07/28
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
11.38%-0.69
-8.60%-0.73
-16.35%-0.74
-23.43%-0.72
-13.97%-0.78
21.95%-0.67
12.36%-0.63
-143.83%-0.59
15.26%-0.68
-16.44%-0.86
---0.72
--1.34
---0.80
---0.74
----
----
----
----
----
----
营业收入
----
--0.00
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-64.40%1.27M
460.45%294.12M
-16.61%35.14M
-17.83%10.28M
-32.66%3.56M
128.78%52.48M
431.88%42.14M
-96.05%12.51M
-43.73%5.29M
292.32%22.94M
净利润
3.40%-128.45M
-12.02%-128.55M
-18.39%-126.90M
-25.34%-124.12M
-30.62%-132.97M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.80M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-31.11%-98.68M
-22.12%-103.30M
3.13%-58.79M
6.88%-65.22M
-130.73%-75.26M
-45.27%-84.59M
-3.29%-60.69M
利润率
----
----
----
----
----
----
----
----
----
----
---7841.59%
--62.35%
---312.40%
---959.62%
----
----
----
----
----
----
毛利率
----
----
----
----
----
----
----
----
----
----
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
资产负债率
0.42%0.44%
-27.85%0.49%
35.86%0.53%
--0.48%
--0.44%
--0.68%
--0.39%
----
----
----
----
----
----
----
----
----
----
----
----
----
营业收入
----
--0.00
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-64.40%1.27M
460.45%294.12M
-16.61%35.14M
-17.83%10.28M
-32.66%3.56M
128.78%52.48M
431.88%42.14M
-96.05%12.51M
-43.73%5.29M
292.32%22.94M
营业利润
5.65%-137.36M
-5.79%-137.37M
-11.57%-137.43M
-15.76%-134.96M
-10.08%-145.58M
2.06%-129.85M
-8.25%-123.19M
-168.39%-116.59M
-9.47%-132.25M
-25.85%-132.57M
-5.87%-113.80M
377.59%170.48M
-81.68%-120.81M
-36.60%-105.34M
-25.58%-107.49M
0.65%-61.42M
6.63%-66.50M
-131.60%-77.12M
-42.38%-85.59M
-0.88%-61.82M
净利润
3.40%-128.45M
-12.02%-128.55M
-18.39%-126.90M
-25.34%-124.12M
-30.62%-132.97M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.80M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-31.11%-98.68M
-22.12%-103.30M
3.13%-58.79M
6.88%-65.22M
-130.73%-75.26M
-45.27%-84.59M
-3.29%-60.69M
流动资产
16.40%1.02B
4.19%900.66M
1.58%882.60M
0.68%934.71M
-9.75%878.64M
-18.77%864.44M
-23.98%868.84M
-24.16%928.38M
-26.53%973.58M
-22.46%1.06B
0.38%1.14B
9.82%1.22B
34.07%1.33B
52.95%1.37B
7.87%1.14B
-16.93%1.11B
-30.96%988.44M
-40.01%897.23M
8.72%1.06B
139.85%1.34B
流动负债总额
19.90%110.16M
-3.77%98.35M
3.51%90.15M
22.17%91.06M
11.26%91.88M
31.07%102.21M
22.36%87.09M
7.46%74.53M
-78.88%82.58M
-78.57%77.98M
-80.26%71.18M
-80.08%69.36M
14.61%391.08M
-3.79%363.92M
564.82%360.67M
577.20%348.16M
524.87%341.24M
427.55%378.25M
-48.53%54.25M
-12.06%51.41M
总资产
-0.42%1.27B
-16.69%1.14B
-27.40%1.06B
-22.38%1.17B
-19.59%1.27B
19.09%1.37B
17.56%1.45B
15.07%1.50B
12.19%1.58B
-20.98%1.15B
0.75%1.24B
1.03%1.31B
6.70%1.41B
3.99%1.46B
-15.34%1.23B
-14.40%1.29B
-14.67%1.32B
-12.47%1.40B
35.47%1.45B
133.23%1.51B
总负债
128.66%339.93M
-9.28%131.09M
-4.50%129.42M
20.49%139.19M
18.34%148.66M
17.51%144.50M
14.41%135.52M
-2.86%115.51M
-71.62%125.62M
-70.57%122.96M
-71.55%118.45M
-70.86%118.91M
9.85%442.64M
-5.44%417.81M
-4.89%416.30M
-6.66%408.01M
-8.94%402.93M
-2.62%441.87M
133.12%437.69M
201.10%437.11M
总权益
-17.51%926.10M
-17.56%1.01B
-29.75%926.20M
-25.95%1.03B
-22.86%1.12B
19.28%1.23B
17.90%1.32B
16.87%1.39B
50.56%1.46B
-1.10%1.03B
37.84%1.12B
34.19%1.19B
5.31%966.71M
8.33%1.04B
-19.85%811.30M
-17.55%884.45M
-16.96%917.93M
-16.36%962.29M
14.70%1.01B
113.62%1.07B
经营净额
0.20%-131.20M
-17.71%-98.54M
-81.43%-107.30M
17.45%-75.30M
-15.71%-131.47M
15.15%-83.72M
32.31%-59.14M
19.39%-91.22M
-93.22%-113.62M
-35.77%-98.66M
-53.14%-87.36M
-163.81%-113.17M
18.45%-58.80M
-10.95%-72.66M
-37.68%-57.05M
20.88%-42.90M
-43.53%-72.11M
-112.74%-65.49M
-48279.07%-41.43M
-25.06%-54.22M
投资净额
403.84%94.46M
-87.94%20.77M
-38.25%57.83M
60.23%157.94M
104.14%18.75M
135.75%172.21M
-7.19%93.66M
-41.35%98.57M
-388.80%-453.19M
157.27%73.05M
554.45%100.91M
89.63%168.07M
21.35%-92.72M
-213.03%-127.56M
129.09%15.42M
-9.13%88.63M
-364.00%-117.88M
88.91%-40.75M
75.01%-53.01M
420.73%97.54M
融资净额
5922.54%219.04M
4709.72%192.13M
95.81%-778.00K
-75.98%1.62M
-100.75%-3.76M
-188.59%-4.17M
-844.74%-18.56M
-25.09%6.76M
31089.21%500.27M
-98.43%4.71M
-51.65%2.49M
104.88%9.02M
9.64%1.60M
5698.20%299.65M
55.48%5.15M
-37.50%4.40M
-61.72%1.46M
-45.73%5.17M
-99.22%3.31M
106.24%7.04M

常见问题

Denali Therapeutics Inc的流动资产是多少?

根据Denali Therapeutics Inc的FY2025财报,流动资产为900.66M(同比变化4.19)。

Denali Therapeutics Inc的总资产是多少?

根据Denali Therapeutics Inc的FY2025财报,Denali Therapeutics Inc的总资产为1.14B(同比变化-16.69)。

Denali Therapeutics Inc的总负债是多少?

根据Denali Therapeutics Inc的FY2025财报,Denali Therapeutics Inc的总负债为131.09M(同比变化-9.28)。

Denali Therapeutics Inc的总权益是多少?

根据Denali Therapeutics Inc的FY2025财报,Denali Therapeutics Inc的总权益为1.01B(同比变化-17.56)。

Denali Therapeutics Inc的净营业收入是多少?

根据Denali Therapeutics Inc的FY2025财报,Denali Therapeutics Inc的净营业收入为-555.34M(同比变化-10.65)。

Denali Therapeutics Inc的净投资是多少?

根据Denali Therapeutics Inc的FY2025财报,Denali Therapeutics Inc的净投资为255.28M(同比变化387.62)。

Denali Therapeutics Inc的净融资是多少?

根据Denali Therapeutics Inc的FY2025财报,Denali Therapeutics Inc的净融资为189.22M(同比变化-60.93)。

Denali Therapeutics Inc的每股收益(EPS)是多少?

根据Denali Therapeutics Inc的FY2025财报,每股收益(EPS)为-2.97(同比变化-15.49)。

Denali Therapeutics Inc的净利润是多少?

根据Denali Therapeutics Inc的FY2025财报,净利润为-512.54M(同比变化-21.23)。

Denali Therapeutics Inc的债务与资产比率是多少?

根据Denali Therapeutics Inc的FY2025财报,债务与资产比率为0.49(同比变化-27.85)。

Denali Therapeutics Inc的股东权益回报率(ROE)是多少?

根据Denali Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-45.69(同比变化-22.16)。

Denali Therapeutics Inc的资产回报率(ROA)是多少?

根据Denali Therapeutics Inc的FY2025财报,资产回报率(ROA)为-40.69(同比变化-21.67)。

Denali Therapeutics Inc的营业利润是多少?

根据Denali Therapeutics Inc的FY2025财报,营业利润为-555.34M(同比变化-10.65)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有